SCHEMBL16578524

SCHEMBL16578524

CNC(=O)c1nn(CCc2cccc3ccccc23)cc(OC(C)=O)c1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MTNR1A P48039 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.37
▸ PGR P06401 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ PTGS1 P23219 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ PLK1 P53350 1/20 0.36
▸ ADORA3 P0DMS8 1/20 0.36
▸ ADORA2A P29274 1/20 0.36
▸ ADORA1 P30542 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ CMA1 P23946 1/20 0.35
▸ KDM4A O75164 1/20 0.35
▸ KDM4C Q9H3R0 1/20 0.35
▸ PEX14 O75381 1/20 0.35
▸ DAO P14920 1/20 0.35
▸ LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20751266 0.84 MTNR1A (0.45) MTNR1AALDH1A1SMN1; SMN2PLK1ADORA3
SCHEMBL20750985 0.72 KDM4A (0.49) MTNR1AADORA3ADORA2AADORA1CMA1
SCHEMBL20751136 0.72 KDM4A (0.41) MTNR1AALDH1A1MAPTKDM4AKDM4C
SCHEMBL11508658 0.67 MAPT (0.45) MTNR1ASMN1; SMN2MAPTCMA1KDM4A
SCHEMBL21201531 0.65 HDAC1 (0.42) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL20751178 0.65 MTNR1A (0.40) MTNR1AALDH1A1PGRGAAPTGS1
Alpha-Naphthylacetate SCHEMBL28109043 0.64 ALDH1A1 (0.64) ALDH1A1PGRGAAPTGS1MAPK1
Alpha-Naphthylacetate SCHEMBL14715837 0.64 ALDH1A1 (0.64) ALDH1A1PGRGAAPTGS1MAPK1
Alpha-Naphthylacetate SCHEMBL27862836 0.64 ALDH1A1 (0.64) ALDH1A1PGRGAAPTGS1MAPK1
SCHEMBL16578532 0.63 SLC6A3 (0.46) MTNR1AALDH1A1PGRGAAPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10364226-B2 Pyridazinone compounds and uses thereof ALIOS BIOPHARMA, INC. (US) 2019-07-30 — — US disclosed
EP-3030549-B1 PYRIDAZINONE COMPOUNDS AND USES THEREOF ALIOS BIOPHARMA INC (US) 2019-02-20 — — EP disclosed
WO-2015038660-A1 PYRIDAZINONE COMPOUNDS AND USES THEREOF ALIOS BIOPHARMA, INC. (US) 2015-03-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10364226-B2 Pyridazinone compounds and uses thereof PDXK, PNPO, PLPBP MTNR1A 994/4885ALDH1A1 2151/4885PGR 2026/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback